AMG-208

N/A

Report date: 2022/07/04 19:38:02
NME

Base Information

Drug NameAMG-208
Drug Alias NameAMG-208
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHepatocyte growth factor receptor inhibitors
TargetsHepatocyte growth factor receptor
Therapy Area/IndicationsSolid tumoursProstatic NeoplasmsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesAmgen Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesThe University Of Texas MD Anderson Cancer CenterAmgen Inc
Active IndicationsN/A
Inactive IndicationsSolid tumoursProstatic NeoplasmsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A